Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytokine receptor-like factor 1 (CRLF1) is a secreted protein belonging to the cytokine type I receptor family and is structurally related to receptors in the interleukin-6/gp130 cytokine family[1][2][3][4]. CRLF1 forms either a homodimer or a heterodimer with cardiotrophin-like cytokine factor 1 (CLCF1/CLC)[1][2][3][4][5]. The heterodimeric CRLF1/CLC complex signals via the ciliary neurotrophic factor receptor (CNTFR), gp130, and leukemia inhibitory factor receptor (LIFR), promoting STAT3 activation and cell survival, especially in neuronal cells[1][4][5]. Homodimeric CRLF1 signals independently and is linked to neuroprotection and tissue regeneration, but its precise receptor is unknown[1][5]. Mutations in CRLF1 result in rare syndromes such as cold-induced sweating syndrome and Crisponi syndrome, characterized by autonomic dysfunction and craniofacial anomalies[3][4]. In disease, CRLF1 is upregulated in osteoarthritic cartilage, and promotes fibrotic tissue remodeling via ERK signaling, especially in ligamentum flavum hypertrophy, making it a potential biomarker and therapeutic target for fibrotic and degenerative diseases[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytokine receptor-like factor 1 (CRLF1).